Clinical Trials List
2020-11-06 - 2023-12-26
Phase II
Not yet recruiting2
Recruiting5
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- KAI-WEN HUANG 無
- 蘇東弘 無
- Shih-Jer Hsu 無
- Chun-Jen Liu 無
- 曾岱宗 無
- Chen-Hua Liu 無
- 洪俊銘 無
- 楊宏志 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- I-Cheng Lee 無
- 王苑貞 無
- Chien-Wei Su 無
- Rheun-Chuan Lee 無
- 黃惠君 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 邱彥程 無
- Chiu Hung Chiu 無
- 簡世杰 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ming-Lung Yu 未分科
- 許博堯 未分科
- 梁博程 未分科
- Chia-Yen Dai 未分科
- Wan-Long Chuang 未分科
- 徐成鼎 未分科
- Chung-Feng Huang 未分科
- 黃駿逸 未分科
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chun-Yen Lin 無
- 滕威 無
- Yi-Chung Hsieh 無
- 戴達英 無
- 鄭雅婷 無
- Rong-Nan Chien 無
- Yi-Cheng Chen 無
- I-Shyan Sheen 無
- Chien-Hao Huang 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
18 participants
-
Global
450 participants
